Evaluation of Darolutamide (ODM201) Efficiency on Androgen Receptor Mutants Reported to Date in Prostate Cancer Patients

SIMPLE SUMMARY: Prostate cancer (PCa) is the most commonly diagnosed non-skin cancer in men and one of the leading causes of cancer-related death. The driver of PCa proliferation and growth is the androgen receptor (AR) and inhibiting this receptor is the standard of care for patients, following sur...

पूर्ण विवरण

में बचाया:
ग्रंथसूची विवरण
में प्रकाशित:Cancers (Basel)
मुख्य लेखकों: Lallous, Nada, Snow, Oliver, Sanchez, Christophe, Parra Nuñez, Ana Karla, Sun, Bei, Hussain, Ahmed, Lee, Joseph, Morin, Helene, Leblanc, Eric, Gleave, Martin E., Cherkasov, Artem
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: MDPI 2021
विषय:
Article
ऑनलाइन पहुंच:https://ncbi.nlm.nih.gov/pmc/articles/PMC8230763/
https://ncbi.nlm.nih.gov/pubmed/34208290
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers13122939
टैग : टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!

समान संसाधन